This paper describes the quantitative biosynthesis of oligosaccharides and their sulphation throughout the normal colon, and in the colon of patients with UC. Experiments were performed in vitro on cultured biopsy specimens. These involved incubation with dual isotopes and fractionation of the labelled macromolecular products by gel chromatography.
ditions. The time based rate of 'H-GlcNH, labelling ofmucus in rectal tissue was similar to that in active or inactive UC whereas the rate of "5SO4' labelling was significantly increased in active disease. The 'H specific activities measuring the amount of isotopic incorporation into surface and tissue mucus glycoproteins were increased in patients with active UC compared with normal or inactive subjects. The 35S specific activities did not differ significantly between patients with active UC and those in remission. In the rectum, glycosylation of mucus glycoproteins decreases with the increasing age of the patient. Regional differences in 'H-labelling ofmucus components are reported for ascending colon, transverse colon, sigmoid colon, and rectum. Sulphation (35S-labelling) was higher in all parts of the colon in left sided UC. Results point to accelerated glycosylation of core proteins in the active phase of UC. (Gut 1993; 34: [926] [927] [928] [929] [930] [931] [932] glycoprotein layer either because of defective synthesis or due to bacterial degradation. With a variety of techniques, abnormalities of colorectal mucus glycoprotein have been reported in UC and Crohn's disease.S" These abnormalities mostly involved reduction in carbohydrate content and in the size of the oligosaccharide side chains with an increase in the low molecular weight mannose rich glycoprotein. These findings are consistent with modified glycosylation and alterations in goblet cell differentiation as expressed by lectin binding or specific carbohydrate residues of colorectal mucus.6 By contrast, increased glucosamine synthetase activity, a rate limiting enzyme in glycoprotein biosynthesis, was found in uninvolved rectal mucosa of patients with UC or Crohn's disease. " This paper describes the quantitative biosynthesis of oligosaccharides and their sulphation throughout the normal colon, and in the colon of patients with UC. Experiments were performed in vitro on cultured biopsy specimens. These involved incubation with dual isotopes and fractionation of the labelled macromolecular products by gel chromatography.
Mucus glycoproteins are synthesised by goblet cells of the gastrointestinal tract. They contribute to mucosal integrity' and may serve to regulate the growth of microorganisms at the luminal surface. In the colon, mucosal glycoproteins derived from the goblet cells are more highly sulphated in the distal than in the proximal colon.2 These sulphated glycoproteins are composed of 0-linked oligosaccharide side chains containing fucose, galactose, N-acetylglucosamine, and sialic acids attached to core protein through threonyl and seryl residues via N-acetylgalactosamine. Differences in the extent of glycosylation and sulphation of these glycoproteins have been found in the colon3 although the degree of sulphation is variable and may be dependent on the physiological and pathological conditions prevailing. The biological function of sulphated mucus glycoproteins is not well known although they may have enhanced resistance to enzymic degradation by bacteria. 45 Degradation of the mucus glycoprotein layer may render the colonic epithelium vulnerable to damage and invasion by bacteria. Thus it has been proposed that ulcerative colitis (UC) might be primarily a disorder involving the mucus Rectal biopsies on normal patients andpatients with Uc Patients with UC were divided into two groups. The first group (n=20) included those in remission maintained on sulphasalazine, olsalazine, or mesalazine. The second group (n= 15) consisted of patients in relapse as shown by inflammation on sigmoidoscopy. Other patients with infectious colitis, collagenous colitis, microscopic colitis, or granulomatous colitis were excluded. As normal controls (n = 31), rectal biopsy specimens were taken from patients who were under investigation for colonic symptoms but in whom no abnormality had been found. Gel chromatography Labelled specimens were prepared for chromatographic fractionation by dialysis (cellophane) in the presence of appropriate cold carrier, for 18 hours (twice) at 2°C against 0-05 M Tris HC1 buffer (pH 7) containing 0-02% sodium azide and 0.1 M NaCl. The dialysed solution was concentrated by centrifugation in a Centriprep 10 or 30 apparatus (Amicon Limited, Stonehouse, Gloucester, UK) at 2000 g for 20 minutes to about 0 5 to 0-8 ml.
The labelled concentrate was applied to a gel chromatographic column (Sepharose CL4B, 23-7x2-5 cm internal diameter, total volume 122 ml) prepared in Tris HC1 buffer (0-1 M, pH 7 4) containing sodium azide (0-02% w/v) and sodium chloride (0I1 M). The void volume was 47 ml and fractionation was carried out by upward elution at a rate of 15 to 20 ml/hour. Fraction volumes were in the range of 3-5 ml to 4 ml Isotopic recovery from the column was greater than 90% and located in the void volume fraction both with normal and UC material (Figs lA and B). (Fig 2A) was similar to that in active UC (Fig 2B) whereas 3"S-labelling rate was distinctively raised in the active condition (Fig 2B) . Figure 3 shows the rate of labelling for both isotopes in control tissue. in the rectum. The difference between ascending colon and rectum was significant (p<0-008).
The total incorporation of'H-glucosamine into glycoprotein in the patients with UC was greater than in normal subjects at all sites in the colon (Fig 6) but values for the ascending colon were not significantly different from those in the rectum.
In all sites a similar gradient in specific activ- (3) mucin (1) mucin (2) and (2)) mucin (3) mucin (4) and (4) ities of 3H-labelled glycoconjugate in the surface mucin fraction was found in normal subjects. Glycosylation in left sided UC in remission was slightly higher than that in normal subjects and was particularly enhanced in the rectum.
In the tissue mucin fraction of normal subjects, the biopsy specimens from the ascending, transverse, and sigmoid colon showed almost the same values for newly synthesised mucus although values were lower in the rectum. In left sided UC in remission, values ofglycosylation were similar in all parts of the colon (Fig 7) . Table II summarises the data for the right colon compared with the rectosigmoid.
Sulphation
The specific activities of 35S-sulphate-labelled glycoconjugates from the rectosigmoid of normal subjects was increased compared with those in the proximal (ascending and transverse) colon (Figs 5-7 ; Table II ). In left sided UC in remission, enhanced sulphation (p<O-OOl) was found in the ascending, transverse, and sigmoid colon c R and was similar to that in the rectum, which Rectum 3H-glucosamine (dpm/,ug protein) TC 3H-glucosamine (dpm/p.g protein)
showed the same degree of sulphation as that of normal subjects. The surface mucus fraction from the normal subjects showed a similar gradient in sulphation as the total mucus (Table II) . Sulphation of surface mucus was higher in all parts of the colon in left sided UC in remission compared with those of normal subjects (p<0001), although there was no quantitative difference in each region of the colon.
The tissue mucus fraction of normal subjects gave a similar value in each part of the colon. Enhanced sulphation was found in all regions of left sided UC.
There was good correlation between glycosylation and sulphation ofglycoprotein in the ascending and transverse colon but no correlation was seen in the rectum (Fig 8) . Thus patients with UC may have a basic abnormality in mucus production. Unfortunately it is not possible to be sure whether these changes reflect a primary abnormality, which might render the epithelium more vulnerable to damage, or whether they are secondary effects. Because goblet cells are a heterogenous population'6 and the epithelial crypt cells of patients are known to be dividing more rapidly than normal even when the UC is in histological remission,24 it is conceivable that minor changes in synthesis, composition, and sulphation of mucus might result. Nevertheless, the increase in glycosylation and sulphation in the normal unaffected right colon of patients with left sided disease, especially when they were in good remission, lends support to the hypothesis that the basic defect is within the epithelium. Further studies on regional synthesis of mucus, its regulation, and the composition of the glycoprotein species seems worthwhile in patients with distal disease.
It is envisaged overall that when UC is in its active state, glycosylation of core-protein(s) outstrips subsequent sulphation and results in the formation of less sulphated glycoconjugates. This implied molecular modification is compatible with the histological findings ofdecreased intracellular sulphated glycoprotein accompanying increased inflammation. 6 It is also consistent with the view that accelerated exocytosis of such modified or incomplete glycoconjugates may be promoted in pathologically disturbed tissue. Because sulphation is related to resistance to bacterial attack, it follows that in such circumstances the protective mucus barrier would be impaired during active inflammation. There is no evidence in these studies that UC is associated with an underlying primary defect of sulphation of mucus glycoprotein.
The hypothesis that modification of the mucus barrier in active UC is a salient defect in the disease has to be considered in terms of intracellular glycoprotein biosynthesis, mucus exocytosis, and the maintenance ofcellular functions in exfoliating circumstances. It seems that in active UC the intracellular biosynthesis is accelerated and exocytosis ofsulphated glycoproteins, possibly modified, is enhanced. In remission the results point to exocytosis and biosynthesis becoming more normal but a more highly sulphated glycoprotein is retained intracellularly.
